Off patent drug possibility for Covid. Ursodeoxycholic acid (UDCA), an approved liver disease drug, reduces ACE2 levels on lab-grown cells

[Eucalyptus22]

There seems to be a deal of excitement in certain media areas about research involving UK, European and US researchers on a covid treatment drug. The one in question is an off patent drug ursodeoxycholic acid currently used to treat liver damage so a re-purposing rather than development of a new drug. There is also mention of a roll-out to a bigger trial within the UK.

nature.com/articles/s41586-...

medscape.com/viewarticle/98...

Certainly for us more vulnerable patients this might be a life saver especially as it is already available and doesn't have to go through the normal NICE channels in the UK.

Maybe a glimmer of hope.

Kate

[AussieNeil Partner Administrator]

Thanks Kate, We could do with some hope!

NewAtlas provide a thorough update on this promising UDCA research here:-

New COVID treatment found in old liver drug derived from bear bile

newatlas.com/health-wellbei...

The Conversation covers it here:- A liver disease drug could be repurposed to protect against COVID – new research

theconversation.com/a-liver...

This looks rather promising and hopefully in the reasonably near term. I've take the liberty of extending your title, so that the research is clearly identified, plus I've assigned a topic to your post.

Neil